[Behavior of alpha-ketoacids after certain hypoglycemic agents].
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use*; D001645:Biguanides / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007651:Keto Acids / Q000097:blood*; D008099:Liver; D008297:Male; D010101:Oxygen Consumption; D051381:Rats; D012980:Sodium Salicylate / Q000627:therapeutic use*; D014044:Tolbutamide / Q000627:therapeutic use
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D007651:Keto Acids; D014044:Tolbutamide; D001241:Aspirin; D012980:Sodium Salicylate
Zachowanie sie alfa-ketokwasów po niektórych środkach hipoglikemizujacych.